You may be eligible to participate in the CONTROL-RA study if you:

  • Are between the ages of 18 and 75
  • Have been diagnosed with moderate to severe rheumatoid arthritis
  • Are currently taking etanercept (Enbrel®), adalimumab (Humira®) or their respective biosimilars
  • Are willing to consider changes to your rheumatoid arthritis treatment

Find a CONTROL-RA Study location near you.